Latest from Enhanced

News

Enhanced Genomics appoints Dr Katerina Leftheris to its Board of Directors

9 Jan 2026

Press Release

Enhanced Genomics appoints Dietrich Stephan, Ph.D. as Chair of the Board to lead ambitious growth strategy

10 Jun 2025

Press Release

Enhanced Genomics extends Series A funding to $19 million to drive development of therapeutics pipeline

16 Sept 2025

Press Release

Enhanced Genomics launches suite of 3D multi-omics solutions to accelerate drug development

14 Jan 2025

Press Release

Enhanced Genomics and The ALBORADA Drug Discovery Institute partner to accelerate Alzheimer's drug discovery

24 Jun 2025

Press Release

Dr Chris Torrance – Interview with Dr Lara Marks

7 Jun 2024

Press Release

Enhanced Genomics appoints Dr Katerina Leftheris to its Board of Directors

9 Jan 2026

Press Release

Enhanced Genomics and The ALBORADA Drug Discovery Institute partner to accelerate Alzheimer's drug discovery

24 Jun 2025

Press Release

Enhanced Genomics launches suite of 3D multi-omics solutions to accelerate drug development

14 Jan 2025

Press Release

Enhanced Genomics extends Series A funding to $19 million to drive development of therapeutics pipeline

16 Sept 2025

Press Release

Enhanced Genomics appoints Dietrich Stephan, Ph.D. as Chair of the Board to lead ambitious growth strategy

10 Jun 2025

Press Release

Dr Chris Torrance – Interview with Dr Lara Marks

7 Jun 2024

Press Release

Enhanced Genomics appoints Dr Katerina Leftheris to its Board of Directors

9 Jan 2026

Press Release

Enhanced Genomics extends Series A funding to $19 million to drive development of therapeutics pipeline

16 Sept 2025

Press Release

Enhanced Genomics and The ALBORADA Drug Discovery Institute partner to accelerate Alzheimer's drug discovery

24 Jun 2025

Press Release

Enhanced Genomics appoints Dietrich Stephan, Ph.D. as Chair of the Board to lead ambitious growth strategy

10 Jun 2025

Press Release

Enhanced Genomics launches suite of 3D multi-omics solutions to accelerate drug development

14 Jan 2025

Press Release

Dr Chris Torrance – Interview with Dr Lara Marks

7 Jun 2024

Press Release

Publications

Our team has a world class academic track record and the technology has featured in dozens of publications, including in some of the world's leading scientific journals, with over 5000 citations to date.

Prioritisation of Candidate Genes Underpinning COVID-19 Host Genetic Traits Based on High- Resolution 3D Chromosomal Topology (2021)

frontiers in Genetics

Oct 2021

Cambridge, UK

TOP1 inhibition therapy protects against SARS-CoV-2- induced lethal inflammation (2021)

Cell

May 2021

Cambridge, UK

Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene Promoters

Cell

Sept 2016

Cambridge, UK

Events

Upcoming Events

Past Events

+44 1223 942520

info@enhancedgenomics.com

+44 1223 942520

info@enhancedgenomics.com

+44 1223 942520

info@enhancedgenomics.com